Connect with us

Health

Novel Approach May Improve Chemotherapy against Pancreatic Cancer – Genetic Engineering & Biotechnology News

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive lethal malignancy due to the lack of early diagnosis and limited…

Published

on

Article feature image

A preclinical study by researchers at the Garvan Institute of Medical Research demonstrates a new approach that may improve how effective chemotherapy is for pancreatic ductal adenocarcinoma (PDAC).
The findings are published in the journal Science Advances…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending